skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 12,644  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Database: ProQuest One Psychology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Single-cell spatial landscapes of the lung tumour immune microenvironment
Material Type:
Article
Add to My Research

Single-cell spatial landscapes of the lung tumour immune microenvironment

Nature (London), 2023-02, Vol.614 (7948), p.548-554 [Peer Reviewed Journal]

2023. The Author(s). ;Copyright Nature Publishing Group Feb 16, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-05672-3 ;PMID: 36725934

Full text available

2
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027071 ;PMID: 32955177

Full text available

3
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2019-11, Vol.381 (21), p.2020-2031 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1910231 ;PMID: 31562796

Full text available

4
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer

The New England journal of medicine, 2022-01, Vol.386 (3), p.241-251 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112431 ;PMID: 34534430

Full text available

5
Antibodies against endogenous retroviruses promote lung cancer immunotherapy
Material Type:
Article
Add to My Research

Antibodies against endogenous retroviruses promote lung cancer immunotherapy

Nature (London), 2023-04, Vol.616 (7957), p.563-573 [Peer Reviewed Journal]

2023. The Author(s). ;Copyright Nature Publishing Group Apr 20, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-023-05771-9 ;PMID: 37046094

Full text available

6
The evolution of lung cancer and impact of subclonal selection in TRACERx
Material Type:
Article
Add to My Research

The evolution of lung cancer and impact of subclonal selection in TRACERx

Nature (London), 2023-04, Vol.616 (7957), p.525-533 [Peer Reviewed Journal]

2023. The Author(s). ;Copyright Nature Publishing Group Apr 20, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-023-05783-5 ;PMID: 37046096

Full text available

7
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709937 ;PMID: 28885881

Full text available

8
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
Material Type:
Article
Add to My Research

Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

The New England journal of medicine, 2020-10, Vol.383 (14), p.1328-1339 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1917346 ;PMID: 32997907

Full text available

9
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801005 ;PMID: 29658856

Full text available

10
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-02, Vol.388 (6), p.489-498 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212083 ;PMID: 36780674

Full text available

11
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Material Type:
Article
Add to My Research

Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer

Nature (London), 2017-05, Vol.545 (7654), p.360-364 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group May 18, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature22323 ;PMID: 28489825

Full text available

12
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
Material Type:
Article
Add to My Research

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

The New England journal of medicine, 2023-07, Vol.389 (2), p.137-147 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2304594 ;PMID: 37272535

Full text available

13
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Material Type:
Article
Add to My Research

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809697 ;PMID: 30280658

Full text available

14
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Material Type:
Article
Add to My Research

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (21), p.1976-1986 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1716078 ;PMID: 29658848

Full text available

15
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer
Material Type:
Article
Add to My Research

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer

Nature (London), 2021-12, Vol.600 (7888), p.319-323 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Dec 9, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04135-5 ;PMID: 34819663

Full text available

16
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Material Type:
Article
Add to My Research

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Nature (London), 2017-06, Vol.546 (7656), p.168-172 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Jun 1, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature22359 ;PMID: 28538732

Full text available

17
Lung cancer: current therapies and new targeted treatments
Material Type:
Article
Add to My Research

Lung cancer: current therapies and new targeted treatments

The Lancet (British edition), 2017-01, Vol.389 (10066), p.299-311 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 21, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)30958-8 ;PMID: 27574741 ;CODEN: LANCAO

Full text available

18
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Material Type:
Article
Add to My Research

A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy

Nature (London), 2017-11, Vol.551 (7681), p.517-520 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Nov 23, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature24473 ;PMID: 29132144

Full text available

19
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
Material Type:
Article
Add to My Research

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

The New England journal of medicine, 2020-01, Vol.382 (1), p.41-50 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1913662 ;PMID: 31751012

Full text available

20
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
Material Type:
Article
Add to My Research

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

The New England journal of medicine, 2020-11, Vol.383 (21), p.2018-2029 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2027187 ;PMID: 33207094

Full text available

Results 1 - 20 of 12,644  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (12,114)

Refine My Results

Creation Date 

From To
  1. Before 1961  (184)
  2. 1961 To 1975  (681)
  3. 1976 To 1990  (1,781)
  4. 1991 To 2006  (3,267)
  5. After 2006  (6,737)
  6. More options open sub menu

Language 

  1. English  (12,601)
  2. Japanese  (1,036)
  3. Spanish  (21)
  4. Polish  (15)
  5. German  (8)
  6. French  (5)
  7. Turkish  (5)
  8. Russian  (3)
  9. Italian  (3)
  10. Norwegian  (3)
  11. Portuguese  (2)
  12. More options open sub menu

Searching Remote Databases, Please Wait